Perspective Therapeutics announced data presentations at ASCO 2025 for its cancer treatment programs [212Pb]VMT-α-NET and [212Pb]VMT01. Perspective Therapeutics, Inc. announced that it will present ...

BIVI presented yesterday blinded clinical, imaging and biomarker outcome data of it phase 3 Alzheimer's Disease trial. Consistent improvements were seen in all above measures, which is suggestive of a ...

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq: INCY) today announced that the Company will present new data from across its oncology portfolio at the 2024 American Society of Hematology (ASH) ...

Crinetics Pharmaceuticals, Inc. announced that eight abstracts detailing their clinical development programs will be presented at the Endocrine Society's Annual Meeting, ENDO 2025. The presentations ...

Good morning, and welcome to the Transgene conference call. [Operator Instructions] As a reminder, this call is being recorded, and a replay will be made available on the Transgene website following ...

SAN DIEGO--(BUSINESS WIRE)--Lassen Therapeutics, a clinical stage biotech company developing first-in-class antibody therapeutics targeting interleukin-11 receptor (IL-11R) and interleukin-18 binding ...

Since COVID-19 emerged late last year, there's been an enormous amount of research produced on this novel coronavirus disease. But the content publicly available for this data and the format in which ...